-
公开(公告)号:US20050164992A1
公开(公告)日:2005-07-28
申请号:US11084454
申请日:2005-03-17
申请人: Yariv Donde , Jeremiah Nguyen , Karen Kedzie , Daniel Gil , John Donello , Wha-Bin Im
发明人: Yariv Donde , Jeremiah Nguyen , Karen Kedzie , Daniel Gil , John Donello , Wha-Bin Im
IPC分类号: A61K31/5575 , C07C405/00 , C07D333/56 , C07D333/62 , C07D409/08 , A61K31/557 , A61K31/66
CPC分类号: C07D333/56 , A61K31/557 , A61K31/5575 , A61K31/559 , C07C57/26 , C07C57/48 , C07C59/90 , C07C69/732 , C07C69/738 , C07D333/62 , C07D409/08
摘要: Disclosed herein is a method comprising administering a compound to a mammal suffering from an inflammatory bowel disease for the treatment of said disease, said compound having a structure according to Formula I wherein X, Y, B, R2, R3, R4, R5, R6 and n have the meanings found herein.
摘要翻译: 本文公开了一种方法,其包括向患有炎症性肠病的哺乳动物施用化合物用于治疗所述疾病,所述化合物具有式I的结构,其中X,Y,B,R 2, R 3,R 4,R 5,R 6和n具有本文找到的含义。
-
公开(公告)号:US07855226B2
公开(公告)日:2010-12-21
申请号:US11084454
申请日:2005-03-17
申请人: Yariv Donde , Jeremiah H. Nguyen , Karen M. Kedzie , Daniel W. Gil , John E. Donello , Wha-Bin Im
发明人: Yariv Donde , Jeremiah H. Nguyen , Karen M. Kedzie , Daniel W. Gil , John E. Donello , Wha-Bin Im
CPC分类号: C07D333/56 , A61K31/557 , A61K31/5575 , A61K31/559 , C07C57/26 , C07C57/48 , C07C59/90 , C07C69/732 , C07C69/738 , C07D333/62 , C07D409/08
摘要: Disclosed herein is a method comprising administering a compound to a mammal suffering from an inflammatory bowel disease for the treatment of said disease, said compound having a structure according to Formula I wherein X, Y, B, R2, R3, R4, R5, R6 and n have the meanings found herein.
摘要翻译: 本文公开了一种方法,其包括向患有炎性肠病的哺乳动物施用化合物用于治疗所述疾病,所述化合物具有式I的结构,其中X,Y,B,R2,R3,R4,R5,R6 并且n具有本文找到的含义。
-
公开(公告)号:US08754122B2
公开(公告)日:2014-06-17
申请号:US12945013
申请日:2010-11-12
申请人: Yariv Donde , Jeremiah H. Nguyen , Karen M. Kedzie , Daniel W. Gil , John E. Donello , Wha-Bin Im
发明人: Yariv Donde , Jeremiah H. Nguyen , Karen M. Kedzie , Daniel W. Gil , John E. Donello , Wha-Bin Im
IPC分类号: A61K31/557 , A61K31/5575 , A61K31/559
CPC分类号: C07D333/56 , A61K31/557 , A61K31/5575 , A61K31/559 , C07C57/26 , C07C57/48 , C07C59/90 , C07C69/732 , C07C69/738 , C07D333/62 , C07D409/08
摘要: Disclosed herein is a method comprising administering a compound to a mammal suffering from an inflammatory bowel disease for the treatment of said disease, said compound having a structure according to Formula I wherein X, Y, B, R2, R3, R4, R5, R6 and n have the meanings found herein.
摘要翻译: 本文公开了一种方法,其包括向患有炎性肠病的哺乳动物施用化合物用于治疗所述疾病,所述化合物具有式I的结构,其中X,Y,B,R2,R3,R4,R5,R6 并且n具有本文找到的含义。
-
公开(公告)号:US20110172435A1
公开(公告)日:2011-07-14
申请号:US12945013
申请日:2010-11-12
申请人: Yariv Donde , Jeremiah H. Nguyen , Karen M. Kedzie , Daniel W. Gil , John E. Donello , Wha-Bin Im
发明人: Yariv Donde , Jeremiah H. Nguyen , Karen M. Kedzie , Daniel W. Gil , John E. Donello , Wha-Bin Im
IPC分类号: C07D257/04 , C07D333/52 , C07C69/738 , C07C59/90
CPC分类号: C07D333/56 , A61K31/557 , A61K31/5575 , A61K31/559 , C07C57/26 , C07C57/48 , C07C59/90 , C07C69/732 , C07C69/738 , C07D333/62 , C07D409/08
摘要: Disclosed herein is a method comprising administering a compound to a mammal suffering from an inflammatory bowel disease for the treatment of said disease, said compound having a structure according to Formula I wherein X, Y, B, R2, R3, R4, R5, R6 and n have the meanings found herein.
摘要翻译: 本文公开了一种方法,其包括向患有炎性肠病的哺乳动物施用化合物用于治疗所述疾病,所述化合物具有式I的结构,其中X,Y,B,R2,R3,R4,R5,R6 并且n具有本文找到的含义。
-
公开(公告)号:US20110152328A1
公开(公告)日:2011-06-23
申请号:US12988168
申请日:2009-04-13
申请人: Scott M. Whitcup , Robert M. Burk , David W. Old , Yariv Donde , Wha-Bin Im , Mark A. Holoboski
发明人: Scott M. Whitcup , Robert M. Burk , David W. Old , Yariv Donde , Wha-Bin Im , Mark A. Holoboski
IPC分类号: A61K31/426 , A61K31/192 , A61K31/4025 , A61K31/4155 , A61K31/421 , A61K31/427 , A61K31/381 , A61P27/06
CPC分类号: A61K45/06 , A61K31/4025 , A61K31/4178 , A61K31/422 , A61K31/427 , A61K31/557 , A61K31/5575 , A61K31/559 , A61K2300/00
摘要: Disclosed herein is method of treating glaucoma or ocular hypertension comprising administering a prostaglandin agonist and a second therapeutically active agent to a mammal in need thereof, wherein said second therapeutically active agent is selected from: β-Blockers, Adrenergic Agonists, non-selective adrenergic agonists, α2-selective adrenergic agonists, Carbonic Anhydrase Inhibitors, Cholinergic Agonists, direct acting cholinergic agonists, chlolinesterase inhibitors, Glutamate Antagonists, Ca2+ channel blockers, Prostamides, Prostaglandins, Cannabinoids, and combinations thereof. Compositions and medicaments containing a combination of these two active agents are also disclosed.
摘要翻译: 本文公开了治疗青光眼或高眼压症的方法,其包括向有需要的哺乳动物施用前列腺素激动剂和第二治疗活性剂,其中所述第二治疗活性剂选自:β-阻滞剂,肾上腺素能激动剂,非选择性肾上腺素能 激动剂,α2-选择性肾上腺素能激动剂,碳酸酐酶抑制剂,胆碱能激动剂,直接作用的胆碱能激动剂,胆碱酯酶抑制剂,谷氨酸拮抗剂,Ca2 +通道阻断剂,前列腺素,大麻素及其组合。 还公开了含有这两种活性剂的组合的组合物和药物。
-
6.
公开(公告)号:US20080132543A1
公开(公告)日:2008-06-05
申请号:US11574528
申请日:2005-10-24
申请人: Wha Bin Im , Yariv Donde , Mark Holoboski , David W. Old , Karen M. Kedzie , Daniel W. Gil , John E. Donello , Robert M. Burk , Todd Gac
发明人: Wha Bin Im , Yariv Donde , Mark Holoboski , David W. Old , Karen M. Kedzie , Daniel W. Gil , John E. Donello , Robert M. Burk , Todd Gac
IPC分类号: A61K31/557 , C07C405/00 , C07D211/74 , C07D207/12 , C07D277/14 , A61K31/559 , C07D263/20 , C07D333/50 , A61P29/00
CPC分类号: C07C405/00 , A61K47/549 , A61K47/64
摘要: A compound comprising a prodrug of a prostaglandin EP4 agonist, wherein said prodrug is an ester, ether, or amide of a carbohydrate; or said prodrug is an ester, ether, or amide of an amino acid is disclosed herein.Maintenance of the colonic mucosal barrier by method comprising administering a therapeutically effective amount of a prostaglandin EP4 agonist to a colon of a mammal is also disclosed herein.Dosage forms, medicaments, and compositions, related thereto are also disclosed.
摘要翻译: 包含前列腺素EP 4激动剂的前药的化合物,其中所述前药是碳水化合物的酯,醚或酰胺; 或所述前体药物是本文公开的氨基酸的酯,醚或酰胺。 通过包括向哺乳动物的结肠施用治疗有效量的前列腺素EP 4激动剂的方法维持结肠粘膜屏障也在本文中公开。 还公开了与其相关的剂型,药物和组合物。
-
公开(公告)号:US20070259836A1
公开(公告)日:2007-11-08
申请号:US11738307
申请日:2007-04-20
申请人: Yariv Donde , Jeremiah Nguyen
发明人: Yariv Donde , Jeremiah Nguyen
IPC分类号: A61K31/66 , A61K31/558 , A61K31/557
CPC分类号: C07C69/732 , C07B2200/07 , C07C57/54 , C07C57/62 , C07C57/68 , C07C59/56 , C07C59/72 , C07C65/19 , C07C65/26 , C07C205/56 , C07C255/57 , C07C309/10 , C07C309/42 , C07C323/17 , C07C323/52 , C07C323/56 , C07C2601/02 , C07C2601/04 , C07C2601/08 , C07C2602/08 , C07D277/24 , C07D277/56 , C07D307/68 , C07D333/16 , C07D333/38 , C07D333/40 , C07D335/06 , C07D405/10 , C07D409/10 , C07F9/3834 , C07F9/3882 , C07F9/65515
摘要: Described herein are compounds having a formula and therapeutic methods, compositions, and medicaments, related thereto.
摘要翻译: 本文描述的是具有式的化合物及其相关的治疗方法,组合物和药物。
-
公开(公告)号:US20060106088A1
公开(公告)日:2006-05-18
申请号:US10991284
申请日:2004-11-16
申请人: Yariv Donde , Robert Burk , Michael Garst , Jeremiah Nguyen
发明人: Yariv Donde , Robert Burk , Michael Garst , Jeremiah Nguyen
IPC分类号: A61K31/381 , C07D333/52
CPC分类号: C07D333/62 , C07C405/0025 , C07D333/56
摘要: Disclosed herein are compounds comprising or a pharmaceutically acceptable salt or a prodrug thereof, wherein a dashed line represents the presence or absence of a bond; Y is a carboxylic acid, sulfonic acid, or phosphonic acid functional group; or an amide or ester thereof comprising from 0 to 12 carbon atoms; or Y is hydroxymethyl or an ether thereof comprising from 0 to 12 carbon atoms; or Y is a tetrazolyl functional group; A is —(CH2)6—, cis —CH2—CH═CH—(CH2)3—, or —CH2—C≡C—(CH2)3— wherein 1 or 2 carbons may be substituted with S or O; B is hydrogen, C1-6 hydrocarbyl, CN, CO2H, or —(CH2)mX(CH2)pH, wherein m is at least 1 and the sum of m and p is from 1 to 5; X is S or O; J is H, CH3, or CF3; D is a covalent bond, CH2, O, or S; and E is an aromatic heterobicyclic ring system which may have substituents comprising up to 6 non-hydrogen atoms each. Methods, compositions, and medicaments related thereto are also disclosed.
摘要翻译: 本文公开了包含其药学上可接受的盐或其前药的化合物,其中虚线表示存在或不存在键; Y是羧酸,磺酸或膦酸官能团; 或其包含0至12个碳原子的酰胺或酯; 或Y是含有0至12个碳原子的羟甲基或其醚; 或Y为四唑基官能团; A是 - (CH 2 CH 2)6 - ,顺式-CH 2 -CH-CH-(CH 2 CH 2) )3 - 或 - CH 2-C≡C-(CH 2)3 - 其中1或 2个碳可以被S或O取代; B是氢,C 1-6烃基,CN,CO 2 H或 - (CH 2 CH 2)m H 其中m至少为1,m和p之和为1至5; X是S或O; J是H,CH 3或CF 3; D是共价键,CH 2,O或S; 并且E是芳族杂双环系统,其可以具有各自包含多达6个非氢原子的取代基。 还公开了与之相关的方法,组合物和药物。
-
公开(公告)号:US20060148894A1
公开(公告)日:2006-07-06
申请号:US11009298
申请日:2004-12-10
申请人: Yariv Donde , Jeremiah Nguyen
发明人: Yariv Donde , Jeremiah Nguyen
IPC分类号: A61K31/557 , C07C69/76
CPC分类号: C07C405/00 , C07C59/56 , C07C59/90 , C07C2601/04 , C07C2601/14
摘要: Compounds comprising are disclosed, wherein Y, A, X, R, D, and n are as described. A compound comprising a prostaglandin EP2 selective agonist wherein the ω-chain comprises a substituted phenyl, wherein at least one substituent consists of hydrocarbyl or non-linear hydroxyhydrocarbyl is also disclosed herein. Methods, compositions, and medicaments related thereto are also disclosed.
-
公开(公告)号:US09006464B2
公开(公告)日:2015-04-14
申请号:US12265062
申请日:2008-11-05
申请人: Yariv Donde , Jeremiah H. Nguyen , Robert M. Burk
发明人: Yariv Donde , Jeremiah H. Nguyen , Robert M. Burk
IPC分类号: C07D333/40 , A61K31/381 , C07D263/34
CPC分类号: C07D333/40 , C07D263/34
摘要: Disclosed herein are compounds having a formula: Therapeutic methods, medicaments, and compositions related thereto are also disclosed.
摘要翻译: 本文公开了具有下式的化合物:还公开了治疗方法,药物和与其有关的组合物。
-
-
-
-
-
-
-
-
-